Bridgeway Capital Management’s BIND THERAPEUTICS INC BIND Stock Holding History

Bridgeway Capital Management’s Portfolio BIND Stock Details BIND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-113,593	Closed	-$250K	–	1533
2016 Q1	$250K	Hold	113,593	–	–	﹤0.01%	1257
2015 Q4	$260K	Buy	113,593 +30,000	+36%	+$121K	﹤0.01%	1244
2015 Q3	$373K	Buy	83,593 +48,593	+139%	+$238K	0.01%	1155
2015 Q2	$196K	Sell	35,000 -28,700	-45%	-$178K	﹤0.01%	1360
2015 Q1	$350K	Hold	63,700	–	–	0.01%	1212
2014 Q4	$344K	Buy	63,700 +29,983	+89%	+$225K	0.01%	1188
2014 Q3	$290K	Buy	+33,717	New	+$332K	0.01%	1276

Other funds holding BIND

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

FMA

FNY Managed Accounts New York $83.4M AUM 11.55% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Bridgeway Capital Management's BIND Position: Q2 2016 in Review

Bridgeway Capital Management sold out of BIND THERAPEUTICS INC (BIND) in Q2 2016, closing a stake of 113,593 shares — an estimated $250K sold.

Bridgeway Capital Management first reported a position in BIND in Q3 2014 and held it in 7 quarters. The position peaked at $373K in Q3 2015. 21 funds tracked by Wall St. Rank hold BIND as of Q2 2016.

Bridgeway Capital Management reported no remaining BIND THERAPEUTICS INC position as of Q2 2016 after selling out during the quarter.
Bridgeway Capital Management sold 113,593 BIND THERAPEUTICS INC shares in Q2 2016, an estimated $250K.
Bridgeway Capital Management first reported a position in BIND THERAPEUTICS INC in Q3 2014 and held it in 7 quarters.
Bridgeway Capital Management's BIND THERAPEUTICS INC position peaked at $373K in Q3 2015.
21 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q2 2016.

Based on Bridgeway Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.